Request Trial

Pharma news

Reset all filters
Geography
Company
Refine search
Boehringer teams up with Gubra to develop second obesity treatment
Pharma
Boehringer teams up with Gubra to develop second obesity treatment
German pharmaceutical company Boehringer Ingelheim has entered into a second licence and collaboration agreement with Danish biotech company Gubra for the development of an obesity treatment.   30 May 2019
GSK settles TM suit over dry-mouth product
Pharma
GSK settles TM suit over dry-mouth product
GSK has entered into a settlement agreement with California-based Laclede, ending a trademark infringement dispute between the pair.   28 May 2019
CMA accuses 4 pharma companies of anti-competitive conduct
Pharma
CMA accuses 4 pharma companies of anti-competitive conduct
Four pharmaceutical companies allegedly agreed not to compete for the supply of an anti-nausea tablet to the National Health Service, according to objections filed by the UK Competition and Markets Authority.   24 May 2019
Pharma
‘Considerable increase’ in pay-for-delay settlements: FTC report
The number of ‘pay-for-delay’ patent settlements reached in fiscal year 2016 represented a “considerable increase” from the previous year, according to a Federal Trade Commission report released yesterday, May 23, though there has been a considerable reduction in the most problematic settlements since 2013.   24 May 2019
Pharma
City of Baltimore accuses Janssen of delaying generics
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is being sued for “unlawfully” delaying generic competition to Zytiga, its branded cancer medication.   23 May 2019
Americas
Merck boosts oncology pipeline with $1bn deal
Merck has announced plans to acquire Peloton Therapeutics, a clinical-stage biopharmaceutical company, in a $1.05 billion bid to boost its oncology pipeline.   22 May 2019
Americas
Alphabet's Verily in digital research alliance with Pfizer and others
Verily, which is a subsidiary of Google’s parent company Alphabet, yesterday announced that it had partnered with Novartis, Otsuka, Pfizer, and Sanofi in efforts to develop digitally-innovative clinical research programmes.   22 May 2019
Pharma
Shire Pharmaceuticals: A culture of excellence
LSIPR provides a look behind the scenes of Shire Pharmaceuticals, the Irish company valued at £46 billion by its acquirer Takeda.   21 May 2019
Pharma
Genentech enters agreement to develop autoimmune therapies
US-based biopharmaceutical company Parvus Therapeutics has entered into a collaboration and licensing agreement with Genentech, a subsidiary of Roche.   21 May 2019
Americas
Antibody patents: Danger ahead for biologics
The evolution of antibody written description standards at the USPTO has put some drug portfolios at risk, say John Heithaus and Gerald Murphy of Birch, Stewart, Kolasch & Birch.   20 May 2019